AFF2 anticorps (Middle Region)
Aperçu rapide pour AFF2 anticorps (Middle Region) (ABIN1449867)
Antigène
Voir toutes AFF2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Séquence
- AMGNCNNGPV TIPQRIHHMA ASHVNITSNV LRGYEHWDMA DKLTRENKEF
-
Réactivité croisée (Details)
- Species reactivity (expected):Mouse, Rat, Horse, Rabbit, Guinea PigSpecies reactivity (tested):Human
-
Purification
- Purified using peptide immunoaffinity column
-
Immunogène
- Synthetic peptide directed towards the middle region of human AFF2
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Add 50 μL of distilled water to a final concentration of 1 mg/mL.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.
-
-
- AFF2 (AF4/FMR2 Family, Member 2 (AFF2))
-
Autre désignation
- AFF2 / FMR2
-
Sujet
- AFF2 is a RNA-binding protein and might be involved in alternative splicing regulation through an interaction with G-quartet RNA structure. Defects in AFF2 are the cause of mental retardation X-linked associated with fragile site FRAXE (MRFRAXE). A form of mild to moderate mental retardation associated with learning difficulties, communication deficits, attention problems, hyperactivity, and autistic behavior. It is associated with a fragile site on chromosome Xq28.Synonyms: AF4/FMR2 family member 2, Fragile X E mental retardation syndrome protein, Fragile X mental retardation 2 protein, Protein Ox19
-
ID gène
- 2334
-
NCBI Accession
- NP_002016
Antigène
-